Evidence map›Paper›PMID 40529815›Full record

ArticleThe Lancet regional health. Western Pacific2025

Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling study.

Hongjiang Wu, Haobin Zhou, Chuiguo Huang, Aimin Yang, Eric S H Lau, Xinge Zhang, Baoqi Fan, Ronald C W Ma, Alice P S Kong, Elaine Chow and 4 more

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hongjiang WuDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Haobin ZhouThe First School of Clinical Medicine, Guangzhou Medical School, People's Republic of China.
Chuiguo HuangDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Aimin YangDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Eric S H LauDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Xinge ZhangDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Baoqi FanDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Ronald C W MaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Alice P S KongDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Elaine ChowDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Wing-Yee SoDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Juliana N M LuiDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Juliana C N ChanDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
Andrea O Y LukDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes has become increasingly prevalent in young populations who are in their prime working years. We estimated the population-level productivity-adjusted life years (PALYs) lost in the working-age population with type 2 diabetes in Hong Kong. Methods: We constructed life tables for individuals aged 20-64 years with type 2 diabetes, with simulated follow-up until retirement at 65 years. We then re-simulated the life tables for the same cohort with the hypothetical assumption that they did not have diabetes, adjusting for differences in mortality rates, labour force participation rates, and productivity. We calculated diabetes-related PALYs lost and assumed the cost of each PALY to be equivalent to the annual gross domestic product (GDP) per worker. Findings: In 2019, 6.3% (n = 139,610) of men and 4.2% of women (n = 117,670) of working age had diagnosed type 2 diabetes in Hong Kong. Over their working lifetime, diabetes was associated with a 17.0% (95% CIs: 16.9%, 17.1%) reduction in PALYs in men and 27.8% (95% CIs: 27.6%, 28.0%) in women, equivalent to 1.0 (95% CIs: 1.0, 1.0) and 1.1 (95% CIs: 1.1, 1.1) PALYs lost per man and woman, respectively. Younger individuals with diabetes experienced greater per-person PALYs lost than older individuals. Men and women aged 20-24 years lost 3.9 (95% CIs: 3.9, 3.9) and 5.0 (95% CIs: 5.0, 5.0) PALYs per person due to diabetes, compared to 0.3 (95% CIs: 0.3, 0.3) PALYs in both sexes aged 60-64 years. The total PALYs lost resulted in a GDP loss of USD 15.3 (95% CIs: 15.2, 15.4) billion in men and USD 14.5 (95% CIs: 14.4, 14.6) billion in women. Interpretation: Type 2 diabetes was associated with substantial reductions in PALYs and indirect economic costs in Hong Kong, with disproportionate impacts on women and younger populations. Targeted interventions are needed to address these disparities and mitigate the dual burden of health and economic consequences of diabetes. Funding: Direct Grant for Research from The Chinese University of Hong Kong.

Indexed as

DiabetesLife tableProductivity loss

Identifiers

PMID40529815
PMCPMC12173075

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.